Premium
A novel framework for interpretation of data from the fish short‐term reproduction assay (FSTRA) for the detection of endocrine‐disrupting chemicals
Author(s) -
Ankley Gerald T.,
Jensen Kathleen M.
Publication year - 2014
Publication title -
environmental toxicology and chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.1
H-Index - 171
eISSN - 1552-8618
pISSN - 0730-7268
DOI - 10.1002/etc.2708
Subject(s) - vitellogenin , biology , endocrine disruptor , endocrine system , sex steroid , estrogen receptor , androgen receptor , computational biology , estrogen , gonad , bioassay , nuclear receptor , triptorelin , steroid biosynthesis , endocrinology , hormone , steroid , fish <actinopterygii> , transcription factor , ecology , biochemistry , genetics , gonadotropin releasing hormone , gene , fishery , luteinizing hormone , prostate cancer , cancer , breast cancer
The fish short‐term reproduction assay (FSTRA) is a key component of the US Environmental Protection Agency's Endocrine Disruptor Screening Program (EDSP), which uses a weight‐of‐evidence analysis based on data from several assays to identify the potential for chemicals to act as agonists or antagonists of the estrogen or androgen receptors (ER and AR), or inhibitors of steroidogenic enzymes. The FSTRA considers a variety of mechanistic and apical responses in 21‐d exposures with the fathead minnow ( Pimephales promelas ), including plasma steroid and vitellogenin (VTG; egg yolk protein) concentrations, secondary sex characteristics, gonad size and histopathology, and egg production. Although the FSTRA initially was described several years ago, recent data generation associated with implementation of the EDSP highlighted the need for more formal guidance regarding evaluation of information from the assay. The authors describe a framework for interpretation of FSTRA data relative to perturbation of endocrine pathways of concern to the EDSP. The framework considers end points individually and as suites of physiologically related responses relative to pathway identification. Sometimes changes in single end points can be highly diagnostic (e.g., induction of VTG in males by ER agonists, production of male secondary sex characteristics in females by AR agonists); in other instances, however, multiple, related end points are needed to reliably assess pathway perturbation (e.g., AR antagonism, steroid synthesis inhibition). In addition to describing an interpretive framework, the authors demonstrate its practical utility using publicly available FSTRA data for a wide range of known and hypothesized endocrine‐disrupting chemicals. Environ Toxicol Chem 2014;33:2529–2540. Published 2014 Wiley Periodicals Inc., on behalf of SETAC. This article is a US government work and, as such, is in the public domain in the United States of America.